Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 12-2021 | |
| Operating Expenses | 915 | 0 | 519 | 0 |
| Operating Income | -915 | N/A | -519 | N/A |
| Interest Expense | 52 | 0 | 38 | 0 |
| Pre-tax Income | -967 | 0 | -557 | 0 |
| Net Income Continuous | -967 | N/A | -557 | N/A |
| Net Income | $-967 | $N/A | $-557 | $N/A |
| EPS Basic Total Ops | -8.70 | N/A | -1.00 | N/A |
| EPS Basic Continuous Ops | -8.70 | N/A | -1.00 | N/A |
| EPS Diluted Total Ops | -8.70 | N/A | -1.00 | N/A |
| EPS Diluted Continuous Ops | -8.70 | N/A | -1.00 | N/A |
| EBITDA(a) | $-883 | $N/A | $-519 | $N/A |